Search
Ethosuximide
go.drugbank.com/drugs/DB00593ApprovedInvestigationalAn anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
Products: Petinimid 250mg - KapselnDiamorphine
go.drugbank.com/drugs/DB01452ApprovedIllicitSale is forbidden in the United States by Federal statute. (Merck Index, 11th ed) Internationally, diamorphine is controlled under Schedules I and IV of the Single Convention on Narcotic Drugs. … As heroin, it is illegal to manufacture, possess, or sell in the United States and the UK. However, under the name diamorphine, heroin is a legal prescription drug in the United Kingdom.
Synonyms: O,O'-DiacetylmorphineProducts: Diamorphine Hydrochloride Inj 100mg/ml BP, Diamorphine Hydrochloride Inj 30mg/ml BPMegestrol acetate
go.drugbank.com/drugs/DB00351ApprovedInvestigationalVet approvedAs the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer.
Categories: Hormones and Related Agents, Antineoplastic and Immunomodulating AgentsProducts: APO-MEGESTROL 160MG, Linmegestrol - Tab 160mgSultamicillin
go.drugbank.com/drugs/DB12127ApprovedWithdrawnSultamicillin has been used in trials studying the prevention and treatment of Ventilator Associated Pneumonia and Chronic Obstructive Pulmonary Disease (COPD).
Products: BACMICINE 250MG/5 ML, SULTAMICILINA 250MG SUSPENSIONDarbepoetin alfa
go.drugbank.com/drugs/DB00012ApprovedInvestigationalHuman erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.
Categories: Blood and Blood Forming Organs, Amino Acids, Peptides, and ProteinsProducts: ARANESP 20UG FS MIT ANS, ARANESP 100UG FS MIT ANSQuinidine
go.drugbank.com/drugs/DB00908Approved[A38016] It prolongs cellular action potential by blocking sodium and potassium currents. … A phenomenon known as “quinidine syncope” was first described in the 1950s, characterized by syncopal attacks and ventricular fibrillation in patients treated with this drug.
Mixtures: Dextromethorphan hydrobromide and quinidine sulfate, Dextromethorphan Hydrobromide and Quinidine SulphateCategories: Quinine and stereoisomer, Metabolic Side Effects of Drugs and SubstancesCyclophosphamide
go.drugbank.com/drugs/DB00531ApprovedInvestigationalPrecursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the liver to form the active aldophosphamide. … Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.
Synonyms: N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxideCategories: Antineoplastic and Immunomodulating AgentsCalcium chloride
go.drugbank.com/drugs/DB01164ApprovedInvestigationalIt has several common applications such as brine for refrigeration plants, ice and dust control on roads, and in cement. … It can be produced directly from limestone, but large amounts are also produced as a by-product of the Solvay process. Because of its hygroscopic nature, it must be kept in tightly-sealed containers.
Mixtures: SOLUCION RINGER NO.3, Ringers and DextroseCategories: Alimentary Tract and Metabolism, Blood and Blood Forming OrgansSimethicone
go.drugbank.com/drugs/DB09512ApprovedInvestigational[A228308] It has a favourable safety profile as it is not systemically absorbed.[A228308] Simethicone has been in use since the 1940s[A228303] but was granted FDA approval in 1952.[A228308] … Simethicone is a silicon based surfactant that decreases the surface tension of gastrointestinal gas bubbles to facilitate their elimination.
Mixtures: Gelusil Antacid and Anti-gas, SIMFLAT 40MG/80 MG FİLM KAPLI TABLET, 90 ADETProducts: Phazyme Cap 95mg, Phazyme Cap 125mgNatalizumab
go.drugbank.com/drugs/DB00108ApprovedInvestigational[A261331] On August 24, 2023, the first biosimilar to natalizumab, natalizumab-sztn, was approved by the FDA.[L48041] Natalizumab was approved by the European Commission on September 22, 2023. … In 2006, the FDA reintroduced the drug to the market for multiple sclerosis.[A261326] Natalizumab was further approved by the FDA for the treatment of Crohn's Disease in January 2008.
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsProducts: TYSABRI® SUBCUTÁNEO 150MG/ML